Safety and efficacy of the BRAF inhibitor dabrafenib in relapsed or refractory hairy cell leukemia: a pilot phase-2 clinical trial
| Image |  |
|---|---|
| Description | scientific article published on 17 March 2021 |
| Author/s |
author: Enrico Tiacci Brunangelo Falini |
| Publication date | March 17, 2021 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |